Funded Tech Companies

Juventas Therapeutics

Headquartered in Cleveland, Juventas Therapeutics raised its funding from private investors, Green Cross Holdings and POSCO Venture Capital.

Company Overview

Contact Information

Company Background Information

Overview

Juventas Therapeutics is a privately held biotechnology company developing a pipeline of regenerative therapies to treat life--threatening diseases. The company's lead product, Stromal--cell Derived Factor 1 (SDF--1), has been shown to protect and repair tissue following organ--damage in a broad range of pre--clinical disease models.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/5/2017

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Rahul Aras

        

Chief Medical Officer

Matthew Pollman

        

VP - Operations

Michael Fitzgerald

        

VP - Product Management

Joseph Pastore

        

Company Investors

• Green Cross Holdings
• POSCO Venture Capital
• Oxford Finance
• Venture Investors
• Takeda Ventures
• Glengary
• Early Stage Partners
• Reservoir Venture Partners (Curtis Crocker)
• Fletcher Spaght Ventures
• Triathlon Medical Ventures (George Emont)
• Tri-State Investment Group
• Global Cardiovascular Innovation Center
• TEDCO

Browse more funded tech companies:

Juvenescence | Juvo

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary